Update: 21.05.2024
Last week: 19 week 2024 (06.05.2024 - 12.05.2024)
Last full month: April 2024
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 7 016 | 17.4% | 12.2% | 0.7 | 15 384 396 | 17.1% | 10.2% | 0.6 | 10.5% |
| MoM | 36 442 | 6.8% | 11.5% | 1 | 80 510 850 | 4.8% | 9.7% | 0.8 | -2.7% |
| YTD | 137 923 | 22.8% | 11.1% | 2.5 | 307 948 249 | 51.7% | 9.5% | 2.2 | -4.5% |
| MAT | 366 481 | 31.8% | 10.0% | 1.8 | 761 716 000 | 49.8% | 8.5% | 1.5 | 7.5% |
| BRAINMAX | |||||||||
| WoW | 885 | 5.0% | 100.0% | 0 | 3 288 656 | 6.9% | 100.0% | 0 | 5.0% |
| MoM | 5 008 | 6.7% | 100.0% | 0 | 17 994 700 | 5.5% | 100.0% | 0 | 17.9% |
| YTD | 19 397 | 45.3% | 100.0% | 0 | 70 018 561 | 54.9% | 100.0% | 0 | 45.3% |
| MAT | 52 701 | 123.9% | 100.0% | NA | 185 812 273 | 138.3% | 100.0% | NA | NA |
| GOLDLINE PLUS | |||||||||
| WoW | 17 016 | 11.5% | 45.4% | 0.2 | 52 796 826 | 9.0% | 36.9% | -0.4 | 11.0% |
| MoM | 79 648 | -0.5% | 45.8% | 1 | 250 870 960 | -0.3% | 37.3% | 1.2 | -2.7% |
| YTD | 322 820 | -1.0% | 44.6% | 1.6 | 1 026 902 222 | 4.0% | 36.4% | -2.6 | -4.4% |
| MAT | 865 892 | 13.9% | 45.5% | 1.6 | 2 730 796 016 | 22.4% | 38.6% | -0.3 | 9.9% |
| MIGRENIUM | |||||||||
| WoW | 10 816 | -1.7% | 0.5% | -0.1 | 3 537 785 | -1.2% | 0.7% | -0.1 | 11.0% |
| MoM | 61 140 | 15.8% | 0.6% | 0.1 | 19 318 134 | 20.2% | 0.9% | 0.2 | -6.0% |
| YTD | 235 392 | 1.8% | 0.6% | -0.1 | 69 644 922 | 67.0% | 0.7% | 0.2 | 16.8% |
| MAT | 645 648 | 7.0% | 0.5% | 0 | 150 617 123 | 37.4% | 0.5% | 0 | 16.8% |
| MODELAX-N | |||||||||
| WoW | 26 296 | 4.1% | 21.4% | -1.5 | 11 740 592 | 5.6% | 14.1% | -1.1 | 11.6% |
| MoM | 137 404 | -16.6% | 24.9% | -2.5 | 59 188 675 | -14.0% | 16.3% | -1.2 | -8.3% |
| YTD | 595 612 | 52.3% | 23.7% | 5.6 | 247 940 820 | 101.8% | 15.0% | 4.7 | 16.2% |
| MAT | 1 372 474 | 95.9% | 20.7% | 7.6 | 507 866 869 | 123.4% | 12.2% | 4.7 | 24.0% |
| REDUXIN | |||||||||
| WoW | 12 261 | 11.9% | 32.7% | 0.3 | 65 282 797 | 12.7% | 45.7% | 1 | 11.0% |
| MoM | 56 729 | -3.8% | 32.6% | -0.4 | 306 452 225 | -5.6% | 45.6% | -1.1 | -2.7% |
| YTD | 239 531 | -8.0% | 33.1% | -1.3 | 1 299 204 832 | 21.2% | 46.1% | 3.7 | -4.4% |
| MAT | 616 955 | 1.7% | 32.4% | -2.6 | 3 100 184 095 | 23.7% | 43.8% | 0.2 | 9.9% |
| REDUXIN FORTE | |||||||||
| WoW | 3 103 | 0.9% | 8.3% | -0.8 | 13 703 477 | 4.3% | 9.6% | -0.6 | 11.0% |
| MoM | 15 157 | -2.0% | 8.7% | 0.1 | 64 576 943 | -3.1% | 9.6% | 0 | -2.7% |
| YTD | 62 946 | 4.7% | 8.7% | 0.8 | 274 470 914 | 22.3% | 9.7% | 0.9 | -4.4% |
| MAT | 168 859 | 25.9% | 8.9% | 1.1 | 703 491 296 | 38.5% | 9.9% | 1.1 | 9.9% |
| SALVISAR | |||||||||
| WoW | 12 249 | 3.0% | 1.7% | -0.1 | 5 128 676 | 1.7% | 1.6% | -0.1 | 6.4% |
| MoM | 59 234 | 14.4% | 1.7% | 0.2 | 24 423 069 | 19.0% | 1.6% | 0.2 | 1.1% |
| YTD | 200 785 | -1.3% | 1.4% | -0.1 | 78 535 712 | 19.9% | 1.2% | 0 | 4.3% |
| MAT | 495 842 | -16.1% | 1.2% | -0.3 | 176 790 767 | -11.9% | 1.0% | -0.3 | 7.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 137 923 | 22.8% | 11.1% | 2.5 | 307 948 249 | 51.7% | 9.5% | 2.2 | -4.5% |
| BRAINMAX | 19 397 | 45.3% | 100.0% | 0 | 70 018 561 | 54.9% | 100.0% | 0 | 45.3% |
| GOLDLINE PLUS | 322 820 | -1.0% | 44.6% | 1.6 | 1 026 902 222 | 4.0% | 36.4% | -2.6 | -4.4% |
| MIGRENIUM | 235 392 | 1.8% | 0.6% | -0.1 | 69 644 922 | 67.0% | 0.7% | 0.2 | 16.8% |
| MODELAX-N | 595 612 | 52.3% | 23.7% | 5.6 | 247 940 820 | 101.8% | 15.0% | 4.7 | 16.2% |
| REDUXIN CAPS | 239 531 | -8.0% | 33.1% | -1.3 | 1 299 204 832 | 21.2% | 46.1% | 3.7 | -4.4% |
| REDUXIN FORTE | 62 946 | 4.7% | 8.7% | 0.8 | 274 470 914 | 22.3% | 9.7% | 0.9 | -4.4% |
| SALVISAR | 200 785 | -1.3% | 1.4% | -0.1 | 78 535 712 | 19.9% | 1.2% | 0 | 4.3% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 366 481 | 31.8% | 10.0% | 1.8 | 761 716 000 | 49.8% | 8.5% | 1.5 | 7.5% |
| BRAINMAX | 52 701 | 123.9% | 100.0% | NA | 185 812 273 | 138.3% | 100.0% | NA | NA |
| GOLDLINE PLUS | 865 892 | 13.9% | 45.5% | 1.6 | 2 730 796 016 | 22.4% | 38.6% | -0.3 | 9.9% |
| MIGRENIUM | 645 648 | 7.0% | 0.5% | 0 | 150 617 123 | 37.4% | 0.5% | 0 | 16.8% |
| MODELAX-N | 1 372 474 | 95.9% | 20.7% | 7.6 | 507 866 869 | 123.4% | 12.2% | 4.7 | 24.0% |
| REDUXIN CAPS | 616 955 | 1.7% | 32.4% | -2.6 | 3 100 184 095 | 23.7% | 43.8% | 0.2 | 9.9% |
| REDUXIN FORTE | 168 859 | 25.9% | 8.9% | 1.1 | 703 491 296 | 38.5% | 9.9% | 1.1 | 9.9% |
| SALVISAR | 495 842 | -16.1% | 1.2% | -0.3 | 176 790 767 | -11.9% | 1.0% | -0.3 | 7.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 7 016 | 17.4% | 12.2% | 0.7 | 15 384 396 | 17.1% | 10.2% | 0.6 | 10.5% |
| BRAINMAX | 885 | 5.0% | 100.0% | 0 | 3 288 656 | 6.9% | 100.0% | 0 | 5.0% |
| GOLDLINE PLUS | 17 016 | 11.5% | 45.4% | 0.2 | 52 796 826 | 9.0% | 36.9% | -0.4 | 11.0% |
| MIGRENIUM | 10 816 | -1.7% | 0.5% | -0.1 | 3 537 785 | -1.2% | 0.7% | -0.1 | 11.0% |
| MODELAX-N | 26 296 | 4.1% | 21.4% | -1.5 | 11 740 592 | 5.6% | 14.1% | -1.1 | 11.6% |
| REDUXIN CAPS | 12 261 | 11.9% | 32.7% | 0.3 | 65 282 797 | 12.7% | 45.7% | 1 | 11.0% |
| REDUXIN FORTE | 3 103 | 0.9% | 8.3% | -0.8 | 13 703 477 | 4.3% | 9.6% | -0.6 | 11.0% |
| SALVISAR | 12 249 | 3.0% | 1.7% | -0.1 | 5 128 676 | 1.7% | 1.6% | -0.1 | 6.4% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 36 442 | 6.8% | 11.5% | 1 | 80 510 850 | 4.8% | 9.7% | 0.8 | -2.7% |
| BRAINMAX | 5 008 | 6.7% | 100.0% | 0 | 17 994 700 | 5.5% | 100.0% | 0 | 17.9% |
| GOLDLINE PLUS | 79 648 | -0.5% | 45.8% | 1 | 250 870 960 | -0.3% | 37.3% | 1.2 | -2.7% |
| MIGRENIUM | 61 140 | 15.8% | 0.6% | 0.1 | 19 318 134 | 20.2% | 0.9% | 0.2 | -6.0% |
| MODELAX-N | 137 404 | -16.6% | 24.9% | -2.5 | 59 188 675 | -14.0% | 16.3% | -1.2 | -8.3% |
| REDUXIN CAPS | 56 729 | -3.8% | 32.6% | -0.4 | 306 452 225 | -5.6% | 45.6% | -1.1 | -2.7% |
| REDUXIN FORTE | 15 157 | -2.0% | 8.7% | 0.1 | 64 576 943 | -3.1% | 9.6% | 0 | -2.7% |
| SALVISAR | 59 234 | 14.4% | 1.7% | 0.2 | 24 423 069 | 19.0% | 1.6% | 0.2 | 1.1% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs